Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00136773
Status:
COMPLETED
Last Update Posted:
2011-03-09
First Post:
2005-08-25
Brief Title:
Effects of AmlodipineBenazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
Effects of AmlodipineBenazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus
Status:
COMPLETED
Status Verified Date:
2008-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Type 2 diabetes mellitus is usually associated with high blood pressure which is a risk factor for kidney disease Aggressive blood pressure reduction is an important strategy to protect the kidney and reduce urinary protein which develops with kidney disease This study will evaluate the effects of amlodipinebenazepril in reducing blood pressure and urinary protein in hypertensive subjects with type 2 diabetes mellitus
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None